Verrica Pharmaceuticals Inc. (VRCA)
NASDAQ: VRCA · Real-Time Price · USD
0.990
+0.103 (11.56%)
Nov 21, 2024, 4:00 PM EST - Market closed
Verrica Pharmaceuticals Balance Sheet
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | 2018 - 2014 |
---|---|---|---|---|---|---|---|
Period Ending | Sep '24 Sep 30, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | Dec '19 Dec 31, 2019 | 2018 - 2014 |
Cash & Equivalents | 22.96 | 69.55 | 34.27 | 15.75 | 10.69 | 9.24 | Upgrade
|
Short-Term Investments | - | - | - | 54.6 | 54.78 | 52.78 | Upgrade
|
Cash & Short-Term Investments | 22.96 | 69.55 | 34.27 | 70.35 | 65.47 | 62.02 | Upgrade
|
Cash Growth | -72.77% | 102.92% | -51.28% | 7.46% | 5.57% | -30.95% | Upgrade
|
Receivables | 0.08 | 4.42 | 0.49 | - | - | - | Upgrade
|
Inventory | 2.58 | 1.02 | - | - | - | - | Upgrade
|
Prepaid Expenses | 2.56 | 2.55 | 4.36 | 3.97 | 2.18 | 2.97 | Upgrade
|
Total Current Assets | 28.19 | 77.53 | 39.12 | 74.33 | 67.65 | 64.98 | Upgrade
|
Property, Plant & Equipment | 4.2 | 3.62 | 5.33 | 5.5 | 4.94 | 2.2 | Upgrade
|
Long-Term Deferred Charges | - | - | - | - | 0.1 | - | Upgrade
|
Other Long-Term Assets | 0.54 | 0.45 | 0.28 | 0.3 | 1.47 | 1.24 | Upgrade
|
Total Assets | 32.93 | 81.6 | 44.72 | 80.13 | 74.15 | 68.42 | Upgrade
|
Accounts Payable | 0.97 | 2.46 | 0.51 | 0.85 | 0.35 | 1.19 | Upgrade
|
Accrued Expenses | 6.06 | 8.17 | 2.43 | 3.01 | 2.84 | 2.04 | Upgrade
|
Short-Term Debt | - | - | - | 41.69 | 35.32 | - | Upgrade
|
Current Portion of Leases | 1.16 | 0.7 | 0.3 | 0.25 | 0.2 | 0.13 | Upgrade
|
Current Unearned Revenue | - | - | - | - | 0.5 | - | Upgrade
|
Other Current Liabilities | 12.84 | 5.69 | 0.22 | 0.26 | 0.28 | - | Upgrade
|
Total Current Liabilities | 21.03 | 17.02 | 3.46 | 46.06 | 39.48 | 3.35 | Upgrade
|
Long-Term Debt | 43.31 | 42.87 | - | - | - | - | Upgrade
|
Long-Term Leases | 2.65 | 1.94 | 1.23 | 1.47 | 1.69 | 0.06 | Upgrade
|
Total Liabilities | 66.98 | 61.83 | 4.69 | 47.52 | 41.17 | 3.41 | Upgrade
|
Common Stock | 0.01 | 0 | 0 | 0 | 0 | 0 | Upgrade
|
Additional Paid-In Capital | 256.77 | 250.21 | 203.48 | 171.6 | 136.87 | 126.59 | Upgrade
|
Retained Earnings | -290.83 | -230.45 | -163.45 | -138.97 | -103.89 | -61.19 | Upgrade
|
Comprehensive Income & Other | - | - | - | -0.03 | 0 | -0.39 | Upgrade
|
Total Common Equity | -34.05 | 19.76 | 40.03 | 32.61 | 32.99 | 65.02 | Upgrade
|
Shareholders' Equity | -34.05 | 19.76 | 40.03 | 32.61 | 32.99 | 65.02 | Upgrade
|
Total Liabilities & Equity | 32.93 | 81.6 | 44.72 | 80.13 | 74.15 | 68.42 | Upgrade
|
Total Debt | 47.11 | 45.51 | 1.53 | 43.41 | 37.21 | 0.19 | Upgrade
|
Net Cash (Debt) | -24.15 | 24.04 | 32.75 | 26.95 | 28.26 | 61.83 | Upgrade
|
Net Cash Growth | - | -26.60% | 21.53% | -4.67% | -54.29% | -31.16% | Upgrade
|
Net Cash Per Share | -0.52 | 0.53 | 0.96 | 1.00 | 1.13 | 2.48 | Upgrade
|
Filing Date Shares Outstanding | 45.6 | 42.42 | 41.85 | 27.52 | 25.44 | 25.81 | Upgrade
|
Total Common Shares Outstanding | 45.6 | 42.41 | 41.09 | 27.52 | 25.44 | 25.79 | Upgrade
|
Working Capital | 7.16 | 60.51 | 35.66 | 28.27 | 28.18 | 61.63 | Upgrade
|
Book Value Per Share | -0.75 | 0.47 | 0.97 | 1.18 | 1.30 | 2.52 | Upgrade
|
Tangible Book Value | -34.05 | 19.76 | 40.03 | 32.61 | 32.99 | 65.02 | Upgrade
|
Tangible Book Value Per Share | -0.75 | 0.47 | 0.97 | 1.18 | 1.30 | 2.52 | Upgrade
|
Machinery | 1.86 | 2.17 | 2 | 1.37 | 0.27 | 0.08 | Upgrade
|
Construction In Progress | - | - | 2.54 | 2.73 | 2.86 | 2.03 | Upgrade
|
Leasehold Improvements | 0.05 | 0.05 | 0.05 | 0.05 | 0.1 | 0.07 | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.